Insight Molecular (IMDX) Stock Rises Sharply After Strategic Shift

Last Friday saw a 34.18% increase in Insight Molecular Diagnostics Inc. (NASDAQ: IMDX) shares, which ended the day at $4.24. A major rebranding push preceded the strong upward surge, which caused the company’s stock to rise 57.04% in just one week. Investor confidence in the company’s new emphasis and expanded trajectory outside cancer is reflected […]

Frisco Reports
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.